| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cognitive ability and teen smoking
|
Jürges, Hendrik
|
|
|
21 |
2 |
p. 287-296
|
artikel
|
| 2 |
Corruption and health outcomes within an economic and cultural framework
|
Achim, Monica Violeta
|
|
|
21 |
2 |
p. 195-207
|
artikel
|
| 3 |
Defensive medicine in Europe: a ‘full circle’?
|
Garattini, Livio
|
|
|
21 |
2 |
p. 165-170
|
artikel
|
| 4 |
Economic evaluation of meningococcal vaccines: considerations for the future
|
Christensen, Hannah
|
|
|
21 |
2 |
p. 297-309
|
artikel
|
| 5 |
How averse are the UK general public to inequalities in health between socioeconomic groups? A systematic review
|
McNamara, Simon
|
|
|
21 |
2 |
p. 275-285
|
artikel
|
| 6 |
Measuring horizontal inequity in healthcare utilisation: a review of methodological developments and debates
|
Pulok, Mohammad Habibullah
|
|
|
21 |
2 |
p. 171-180
|
artikel
|
| 7 |
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
|
Campioni, M.
|
|
|
21 |
2 |
p. 219-233
|
artikel
|
| 8 |
The company you keep: health behavior among work peers
|
Pruckner, Gerald J.
|
|
|
21 |
2 |
p. 251-259
|
artikel
|
| 9 |
The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France
|
de Pouvourville, Gérard
|
|
|
21 |
2 |
p. 235-249
|
artikel
|
| 10 |
The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature
|
Rehman, Anees ur
|
|
|
21 |
2 |
p. 181-194
|
artikel
|
| 11 |
The impact of prescription drug co-payments for publicly insured families
|
Mohan, Gretta
|
|
|
21 |
2 |
p. 261-274
|
artikel
|
| 12 |
Why are there long waits at English emergency departments?
|
Gaughan, James
|
|
|
21 |
2 |
p. 209-218
|
artikel
|
Tijdschrift beschrijving